Glenn Deng

CEO

Glenn Deng, PhD, CEO, a successful entrepreneur and a renowned expert in cancer research who was with Stanford Medical School. Dr. Deng owns multiple patents of CTC research and applications.

Christie Hou

CSO

Dr. Hou earned her Ph.D at University of Rochester and did postdoctoral research at UCSF. Also an entrepreneur, Dr. Hou has extensive experience in PCR, gene analysis and novel reagent development while worked at Clontech, Applied Biosystems.

Jing Zhang

CTO

Dr. Zhang worked with IBM, Hitachi and Silicon Valley start-ups. He holds Ph.D. in Electrical and Computer Engineering from Carnegie Mellon University and specializes in biosensor devices and instrumentation.